Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesit... Agentix Corp., a clinical development stage company, focuses on the development and commercialization of novel therapeutics to treat metabolic diseases in the United States. It develops AGTX-2004, a peripherally-acting CB1 receptor antagonist that has demonstrated efficacy in animal models of obesity and type 2 diabetes mellitus; and AGTX-2003, a peripherally-acting CB1 receptor inverse agonist, which has demonstrated efficacy in animal models of obesity and non-alcoholic fatty liver diseases. The company was formerly known as FairWind Energy, Inc. and changed its name to Agentix Corp. in June 2019. Agentix Corp. was founded in 2020 and is based in Dana Point, California. 詳細を表示
| 期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.001566 | 8.49517196485 | 0.018434 | 0.02 | 0.018434 | 140000 | 0.02 | CS |
| 4 | -0.0017 | -7.83410138249 | 0.0217 | 0.03 | 0.0142 | 93181 | 0.01930311 | CS |
| 12 | -0.0239 | -54.4419134396 | 0.0439 | 0.0439 | 0.0142 | 38209 | 0.02228915 | CS |
| 26 | -0.0299 | -59.9198396794 | 0.0499 | 0.05 | 0.0142 | 25272 | 0.02815299 | CS |
| 52 | 0 | 0 | 0.02 | 0.055 | 0.0142 | 19229 | 0.03425691 | CS |
| 156 | -0.04 | -66.6666666667 | 0.06 | 0.46 | 0.0142 | 21064 | 0.05016709 | CS |
| 260 | -1.15 | -98.2905982906 | 1.17 | 1.24 | 0.0142 | 14803 | 0.06705472 | CS |
raiderz
11分前
raiderz
22分前
SDCRBS
22分前
Moe2001
25分前
Tseven
46分前
in99flyers
46分前
rheddle
50分前
daisyfresh
51分前
MarkMonkey
53分前
sandor8
60分前
ご覧いただいた銘柄が下記のボックス内に表示されますので、過去閲覧した銘柄情報に簡単にアクセスすることができます。
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約
すでにアカウントをお持ちですか? サインイン
アカウントをお持ちでないですか? 登録
登録することで、ADVFN の 利用規約 を読み、理解し、同意したこと、および私が個人投資家であることを確認します。